Am J Clin Oncol
- OHAEGBULAM KC, Post CM, Farris PE, Garzotto M, et al
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized
High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
Am J Clin Oncol. 2024 Oct 30. doi: 10.1097/COC.0000000000001151.
BJU Int
- DE ANGELIS M, Siech C, Di Bello F, Rodriguez Penaranda N, et al
Mortality rates in radical cystectomy patients with bladder cancer after
radiation therapy for prostate cancer.
BJU Int. 2024 Oct 27. doi: 10.1111/bju.16571.
BMC Cancer
- SHAO YJ, Liao CS, Hsu YC, Chiu YC, et al
Clinical relevance of protein-truncating variants of germline DNA repair genes in
prostate cancer.
BMC Cancer. 2024;24:1319.
Eur Radiol
- VAN LOHUIZEN Q, Roest C, Simonis FFJ, Fransen SJ, et al
Assessing deep learning reconstruction for faster prostate MRI: visual vs.
diagnostic performance metrics.
Eur Radiol. 2024;34:7364-7372.
- PONSIGLIONE A, Brembilla G, Cuocolo R, Gutierrez P, et al
ESR Essentials: using the right scoring system in prostate MRI-practice
recommendations by ESUR.
Eur Radiol. 2024;34:7481-7491.
- DE ROOIJ M, Allen C, Twilt JJ, Thijssen LCP, et al
PI-QUAL version 2: an update of a standardised scoring system for the assessment
of image quality of prostate MRI.
Eur Radiol. 2024;34:7068-7079.
Eur Urol
- OH WK, Agarwal N, Bryce A, Barata P, et al
What's in a Name? Why Words Matter in Advanced Prostate Cancer.
Eur Urol. 2024 Oct 28:S0302-2838(24)02680-0. doi: 10.1016/j.eururo.2024.
- TOUIJER KA, Vertosick EA, Sjoberg DD, Liso N, et al
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized
Clinical Trial of Limited Versus Extended Dissection.
Eur Urol. 2024 Oct 28:S0302-2838(24)02647-2. doi: 10.1016/j.eururo.2024.
Int J Urol
- OBINATA D, Yamada Y, Sumiyoshi T, Tanegashima T, et al
Recent advances in basic research on prostate cancer: Where we are heading?
Int J Urol. 2024 Oct 30. doi: 10.1111/iju.15628.
J Nucl Med
- SONNI I, Weiner AB, Doddipalli S, Deol M, et al
Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer
Detection by PSMA PET/CT and Multiparametric MRI.
J Nucl Med. 2024 Oct 30:jnumed.124.268443. doi: 10.2967/jnumed.124.268443.
- HUANG RR, Zuo C, Mona CE, Holzgreve A, et al
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in
Castration-Resistant Prostate Cancer: A Translational Pilot Study.
J Nucl Med. 2024 Oct 30:jnumed.124.268037. doi: 10.2967/jnumed.124.268037.
- SWIHA M, Pathmanandavel S, Papa N, Sabahi Z, et al
Comparison of Posttherapy 4- and 24-Hour [(177)Lu]Lu-PSMA SPECT/CT and Pretherapy
PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant
Prostate Cancer.
J Nucl Med. 2024 Oct 30:jnumed.124.267606. doi: 10.2967/jnumed.124.267606.
- MUNIZ M, Sartor O, Orme JJ, Koch RM, et al
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and
Liver Metastasis Receiving [(177)Lu]Lu-PSMA-617.
J Nucl Med. 2024 Oct 30:jnumed.124.268277. doi: 10.2967/jnumed.124.268277.
Magn Reson Med
- LEE PK, Hess JJ, Gomella AA, Loening AM, et al
A diffusion-prepared reduced FOV sequence for prostate MRI near metallic
implants.
Magn Reson Med. 2025;93:261-275.
Prostate
- WHYNE EZ, Jeon-Slaughter H, Kelly K, Dowell JE, et al
Effects of Concurrent Administration of Spironolactone in Veterans with
Metastatic Prostate Cancer Receiving Abiraterone: A Real-World Retrospective
Study.
Prostate. 2024 Oct 28. doi: 10.1002/pros.24811.
- FINATI M, Morrison C, Stephens A, Chiarelli G, et al
Association of race with incidence, characteristics, and mortality from
incidental prostate cancer: Analysis of two North American contemporary cohorts.
Prostate. 2024 Oct 28:e24803. doi: 10.1002/pros.24803.
- WEI X, Zhao J, Nie L, Shi Y, et al
Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P)
in determining abiraterone efficacy for metastatic hormone-sensitive prostate
cancer (mHSPC) patients.
Prostate. 2024 Oct 28. doi: 10.1002/pros.24809.
Radiology
- YANG DD, Lee LK, Tsui JMG, Leeman JE, et al
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized
Prostate Cancer.
Radiology. 2024;313:e240041.
Urol Int
- JI G, Liu F, Chen Z, Peng J, et al
Correlation of magnetic resonance imaging and computed tomography with biological
factor expression and lymph node metastasis in aggressive prostate cancer.
Urol Int. 2024 Oct 25:1-8. doi: 10.1159/000541953.
Urology
- RIVERA LOPEZ CA, Cheaib J, Singla N
Editorial Comment on "Virtual reality as an adjunct to traditional patient
counselling in patients with newly-diagnosed localized prostate cancer".
Urology. 2024 Oct 23:S0090-4295(24)00929-4. doi: 10.1016/j.urology.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016